EU medtech industry keeps eye on Portuguese treaty moves:
This article was originally published in Clinica
Executive Summary
The Portuguese presidency of the EU Council is hoping to secure a political agreement on the European Union treaty by mid-October, and is targeting text sign-off by the end of the year. National leaders were due to meet on September 7 with the aim of strengthening the functioning and management of the 27-member EU. This should enable it to become more influential on a global level, politically and economically, and on an industrial level - with obvious repercussions for the medtech industry, among others. The new treaty, as currently proposed, would provide for a permanent president, and, from 2014, would give national parliaments a greater role. The issue remains highly political, and the text has many opponents.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.